Skip to main content
Log in

Effects of alprazolam and imipramine on parasympathetic cardiac control in patients with generalized anxiety disorder

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

A noninvasive measure was used to assess the effects of alprazolam, imipramine and placebo on parasympathetic (vagal) cardiac control following 6-weeks of medication in patients with generalized anxiety disorder. Flexible dosage at therapeutic levels resulted in increased heart rate and blood pressure and in decreased cardiac vagal control in patients receiving imipramine but not alprazolam or placebo. About 50% of the variance in heart rate changes and changes in mean arterial blood pressure following treatment with imipramine could be accounted for by changes in cardiac vagal control. Decreased cardiac vagal control can now be added to the list of cardiovascular changes seen following several weeks of treatment with imipramine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • American Psychiatric Association Committee on Nomenclature and Statistics (1987) Diagnostic and statistical manual of mental disorders, revised 3rd edn. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Baldessarini RJ (1985) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilman's. The pharmacological basis of therapeutics, 7th edn. Macmillan, New York, pp 387–445

    Google Scholar 

  • Berne RM, Levy MN (1986) Cardiovascular physiology. CV Mosby, St. Louis

    Google Scholar 

  • Billman GE, Dujardin J-P (1990) Dynamic changes in cardiac vagal tone as measured by time series analysis. Am J Physiol 258:H896-H902

    Google Scholar 

  • Cheung MN, Porges SW (1977) Respiratory influences on cardiac responses during attention. Physiol Psychol 5:53–57

    Google Scholar 

  • Eckberg DL (1983) Human sinus arrhythmia as an index of vagal cardiac outflow. J Appl Physiol: Respir Environ Exerc Physiol 54:961–966

    Google Scholar 

  • Giardina EGV, Bigger T Jr, Glassman AH, Perel JM, Kantor SJ (1979) The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation 60:1045–1052

    Google Scholar 

  • Glassman AH, Bigger JT Jr (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 38:815–820

    Google Scholar 

  • Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55

    Google Scholar 

  • Hayano J, Sakakibara Y, Yamada M, Kamiya T, Fujinami T, Yokoyama K, Wantanabe Y, Takata K (1990) Diurnal variations in vagal and sympathetic control. Am J Physiol 258:H642-H646

    Google Scholar 

  • Hoehn-Saric R, McLeod DR, Zimmerli WD (1988) Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry 49:293–301

    Google Scholar 

  • Jakobsen J, Hauksson P, Vestergaard P (1984) Heart rate variation in patients treated with antidepressants. An index of anticholinergic effects? Psychopharmacology 84:544–548

    Google Scholar 

  • Johnsson G, Lundborg P, Welin-Fogelberg I (1979) Interaction studies between three antidepressant drugs (chlorimipramine, imipramine and zemelidine) and noradrenaline, tyramine and vagal stimulation on the heart rate and blood pressure in dogs. Acta Pharmacol Toxicol 45:192–197

    Google Scholar 

  • Katona PG, Lipson D, Dauchot PJ (1977) Opposing central and peripheral effects of atropine on parasympathetic cardiac control. Am J Physiol 232:H146-H151

    Google Scholar 

  • Lopes OU, Palmer JF (1976) Proposed respiratory “gating” mechanism for cardiac slowing. Nature 264:454–456

    Google Scholar 

  • Malik R, Courtney KR, Jensen RA (1979) Imipramine affects autonomic control of sinoatrial rate in isolated right atrial preparations. J Pharmacol Exp Ther 211:284–289

    Google Scholar 

  • McLeod DR, Hoehn-Saric R, Labib AS, Greenblatt DJ (1988) Six weeks of diazepam treatment in normal women: effects on psychomotor performance and psychophysiology. J Clin Psychopharmacol 8:83–99

    Google Scholar 

  • McLeod DR, Hoehn-Saric R, Zimmerli WD, De Souza EB, Oliver LK (1990) Treatment effects of alprazolam and imipramine: physiological versus subjective changes in patients with generalized anxiety disorder. Biol Psychiatry 28:849–861

    Google Scholar 

  • Mohrman DE, Heller LJ (1986) Cardiovascular physiology, 2nd edn. McGraw-Hill, New York

    Google Scholar 

  • Parzen E (1961) Mathematical considerations in the estimation of spectra. Technometrics 3:167–190

    Google Scholar 

  • Porges SW (1985) Method and apparatus for evaluating rhythmic oscillations in aperiodic physiological response systems. US Patent 451 0944, April 16, 1985

  • Porges SW (1986) Respiratory sinus arrhythmia: Physiological basis, quantitative methods, and clinical implications. In: Grossman P, Janssen KHL, Vaitl D (eds) Cardiorespiratory and cardiosomatic psychophysiology. Plenum Press, New York, pp 101–115

    Google Scholar 

  • Porges SW (1991) Vagal mediation of respiratory sinus arrhythmia: implications for drug delivery. Ann NY Acad Sci 618:57–66

    Google Scholar 

  • Porges SW, Bohrer RE (1990) The analysis of periodic processes in psychophysiological research. In: Cacioppo JT, Tassinary LG (eds) Principles of psychophysiology: physical, social, and inferential elements. Cambridge University Press, New York, pp 708–753

    Google Scholar 

  • Risch SC, Groom GP, Janowsky DS (1982) The effects of psychotropic drugs on the cardiovascular system. J Clin Psychiatry 43:16–31

    Google Scholar 

  • Roth WT, Telch MJ, Taylor CB, Agras WS (1988) Autonomic changes after treatment of agoraphobia with panic attacks. Psychiatry Res 24:95–107

    Google Scholar 

  • Rudorfer MV, Potter WZ (1987) Pharmacokinetics of antidepressants. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1353–1363

    Google Scholar 

  • Spitzer RL, Williams JBW, Gibbon M (1987) Instruction manual for the structured clinical interview for DSM-III-R (SCID, 4/1/87 revision). Biometrics Research Department, New York State Psychiatric Institute, New York

  • Taylor CB, Hayward C, King R, Ehlers A, Margraf A, Maddock R, Clark D, Roth WT, Agras WS (1990) Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind placebo controlled trial. J Clin Psychopharmacol 10:112–118

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported in part by NIMH grants MH35435 and MH42579, and by a grant from the Upjohn Company, Kalamazoo, Michigan. We thank Pamela A. Hipsley for assistance in data reduction and manuscript preparation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McLeod, D.R., Hoehn-Saric, R., Porges, S.W. et al. Effects of alprazolam and imipramine on parasympathetic cardiac control in patients with generalized anxiety disorder. Psychopharmacology 107, 535–540 (1992). https://doi.org/10.1007/BF02245268

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245268

Key words

Navigation